2026 Artemetrx State of Specialty Spend and Trend Report
PSG announces the results of the industry’s go-to report on specialty drug spend and trend. With specialty drug costs remaining a top concern…
Read Post
Insights
Categories
Topics
Categories
Topics
Trends in Drug Benefit Design Report Released by Pharmaceutical Strategies Group
Highlights plan sponsors’ strategies to address changing environment (DALLAS, TX) – Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the launch…
Read Post
2023 Trends in Benefit Design Report
Pharmaceutical Strategies Group (PSG) is pleased to present the 2023 Trends in Drug Benefit Design Report, which details traditional (non-specialty) drug benefit trends…
Read Post
The Impact of Insulin Price Decreases on Employers
When Eli Lilly announced a 70% price reduction and a $35 cap on insulin prices, it started a chain reaction that…
Read Post
Value-Based Pharmaceutical Contracts: The Tool Few Payers Are Using — Why?
Value-based care and contracting is receiving substantial attention across the health care landscape as a tool for improving patient care and managing costs, and…
Read Post
The Buzz Around Weight Loss Drugs – What’s Driving It?
Who would have imagined one of the hottest online trends would be pharmaceuticals for weight loss? Social media and commercials are flooded with advertisements…
Read Post
PSG Releases Highly Anticipated ‘Trends in Specialty Drug Benefits Report’
(DALLAS, TX) – Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual Trends in Specialty Drug Benefits report. Delivering…
Read Post
Practical Strategies for Containing Pharmacy Costs
The pharmacy benefit management landscape is complex and ever-changing. With many new high-cost trending therapies currently available in addition to those on the horizon,…
Read Post
Claims Errors Adding Up? Let PSG Solve Your Math Problem
Key Metrics: 7% of PBM claims processed incorrectly $600K of reimbursement dollars due to client Background When a large government organization discovered that their…
Read Post
The Negotiation before the Negotiation: Medicare Drug Price Negotiation Program Initial Guidance
On March 15th the Centers for Medicare and Medicaid Services (CMS) released initial guidance on the Medicare Drug Price Negotiation Program (or “Negotiation…
Read Post
Looking for your perfect PBM? PSG has a knack for match making
Key Metrics: $5B amount saved by PSG’s RFP procurement clients in just one year. Background When planning their annual budget, a national retail employer…
Read Post
Amjevita, First Biosimilar of Humira, Launches With Two-Tiered Pricing Strategy
Republished with Permission from AIS Health More than six years after the FDA approved it, the first biosimilar of AbbVie…
Read Post